Skip to main content

Overview

Skip to main content

Français

Event Details

Evercore ISI 5th Annual HealthConX Conference

from November 29, 2022 to December 1, 2022

virtual

Add to Calendar

Add to Apple Calendar
Add to Google Calendar
Add to Microsoft Outlook
Add to iCalendar

Investor Relations Contact

Stéphanie Cornen
Vice-President, Investor Relations, Communications & Commercial Strategy

Investors@innate-pharma.fr

Investor Email Alerts

To opt-in for investor email alerts, please enter your email address in the field below and select at least one alert option. After submitting your request, you will receive an activation email to the requested email address. You must click the activation link in order to complete your subscription. You can sign up for additional alert options at any time.

At Innate Pharma, we promise to treat your data with respect and will not share your information with any third party. You can unsubscribe to any of the investor alerts you are subscribed to by visiting the ‘unsubscribe’ section below. If you experience any issues with this process, please contact us for further assistance.

By providing your email address below, you are providing consent to Innate Pharma to send you the requested Investor Email Alert updates.

* Required

Email Address *

Investor Alert Options

Investor Alert Options *

News

Quarterly Reports

Annual Reports

SEC Filings

End of Day Stock Quote

Events & Presentations

Unsubscribe Désabonnement

Email Alert Sign Up Confirmation

Contact
Location
Legal Info
Terms of use
Privacy Notice
Cookie Notice

Follow us

Stay in touch

Subscribe to our newsletter

Location

117, Avenue de Luminy - BP 30191
13 009 Marseille FRANCE

+33 (0)4 30 30 30 30

Innate Pharma, Inc.
2273 Research Boulevard, Suite 350
Rockville, MD 20850, USA

Powered By Q4 Inc. 5.172.0.2 (opens in new window)